About Hampsbio
Hampsbio is a company. The company has 34 employees as of March 28, 2024. Hampsbio offers products and services including Pharmaceutical Formulations and Freeze-Dried Ingredients.
- Employees 34 as on 28 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hamps Bio Ltd.
-
Annual Revenue
$780.61 K (USD)2.99as on Mar 31, 2025
-
Net Profit
$34.88 K (USD)-40.53as on Mar 31, 2025
-
EBITDA
$90.01 K (USD)-34.65as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
34
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Hampsbio
Hampsbio is a publicly listed company on the BSE with ticker symbol HAMPS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Hampsbio
Hampsbio offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Freeze-Dried Ingredients.
Various medicines and formulations are manufactured and distributed for therapeutic purposes, covering areas like anti-hypertensive and antibiotics
Freeze-dried fruits, vegetables, and herbs are supplied for use in industries such as tea, soup, and nutrition bars, serving B2B and B2C markets
Funding Insights of Hampsbio
Detailed funding history for Hampsbio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hampsbio
Investment portfolio details for Hampsbio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hampsbio
Detailed financials for Hampsbio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hampsbio Comparisons
Peer comparison for Hampsbio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hampsbio
Detailed competitors of Hampsbio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hampsbio
Complete news archive for Hampsbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hampsbio
As of Mar 28, 2024, the latest employee count at Hampsbio is 34.
Annual revenue of Hampsbio is $780.61K as on Mar 31, 2025.
Operations in the pharmaceutical and food sectors are conducted by Hampsbio, where tablets, capsules, syrups, and injectables are produced alongside freeze-dried fruits, vegetables, herbs, and other ingredients. These products are supplied to business-to-business and business-to-consumer markets, both domestically and internationally. Branded items for direct consumer purchase are also offered, supporting diverse applications in health and nutrition.
Hampsbio offers Pharmaceutical Formulations and Freeze-Dried Ingredients.
Yes, Hampsbio is publicly traded on BSE under the ticker symbol HAMPS.
The ticker symbol of Hampsbio is HAMPS on BSE.